Relationship between glucagon and metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus

doi:10.4254/wjh.v17.i6.104693

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (0)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-5) series.

Item

Count

PDF

HTML

Figures (1-1)

Tables (1-5)

Sum=0

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=0

Jun 27, 2025 (publication date) through Jun 26, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Hepatol. Jun 27, 2025; 17(6): 104693
Published online Jun 27, 2025. doi: 10.4254/wjh.v17.i6.104693

Table 4 Multivariate linear regression analysis of various biomarkers with ultrasound attenuation parameter

	Standard β	t value	P value
Age	0.078	0.991	0.323
WC	-0.005	-0.067	0.947
DBP	-0.048	-0.756	0.451
ALT	0.093	1.258	0.210
SUA	0.034	0.512	0.609
TG	0.033	0.526	0.599
HDL	0.050	0.794	0.428
CP_{0 min}	0.245	3.566	< 0.001
GCG_{0 min}	0.182	2.020	0.045
LSM	0.320	5.144	< 0.001
GPR	-0.094	-1.088	0.278
FIB4	0.085	0.977	0.330

WC: Waist circumference; DBP: Diastolic blood pressure; ALT: Alanine aminotransferase; SUA: Serum uric acid; TG: Triglycerides; HDL: High-density lipoprotein; GCG: Glucagon; CP: C-peptide; LSM: Liver stiffness measurement; GPR: Gamma glutamyl transpeptidase to platelet ratio; FIB4: Fibrosis 4 score.

Citation: Sun Y, Huang P, Zhao XQ, Tang ZQ, Xu TT, Wang XW, Qi ZX, Lin WR, Li MY, Gu YJ. Relationship between glucagon and metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus. World J Hepatol 2025; 17(6): 104693
URL: https://www.wjgnet.com/1948-5182/full/v17/i6/104693.htm
DOI: https://dx.doi.org/10.4254/wjh.v17.i6.104693